In brief
In a landmark award, Karl Deisseroth, Peter Hegemann and Georg Nagel receive the Nobel in Physiology or Medicine for inventing optogenetics, a technique that uses light to probe and control brain circuitry. Their work has illuminated how specific memories and behaviors arise in the nervous system, offering insights into psychiatric and neurological disorders. Clinicians now use the method to attempt visual restoration in patients with sight impairment. The Nobel committee hailed the trio’s research as a foundation for a new era of neurological science and therapeutic innovation.
Nobel Prize spotlights optogenetics: light‑guided cells map emotions
US psychiatrist Karl Deisseroth and his German colleagues Peter Hegemann and Georg Nagel were honoured with this year’s Nobel Prize in Physiology or Medicine for their breakthrough technique called optogenetics. The method employs engineered light‑sensitive proteins to switch neurons on or off with precise illumination, letting scientists observe how the brain encodes memory, mood and behaviour.
Their laboratory experiments revealed the neural circuitry that drives particular feelings and actions, a discovery that the Nobel committee noted could be repurposed to address mental health challenges. Optogenetics has already made an impact on human health: clinicians now use the approach to try to restore vision in people suffering from retinal damage, translating the science from the bench to the clinic.
The award emphasises the shift toward single‑cell resolution in neuroscience. Researchers worldwide are now applying optogenetics to map brain networks in health and disease, offering a roadmap for targeted treatments that were unimaginable a generation ago.
With this prize, the trio not only gains recognition but also validates the potential of light‑controlled therapies to reshape how we treat neurological disorders, opening futures where precise neural manipulation becomes routine in medicine.
